糖尿病外围神经病变的致病基因治疗方法
1Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Diabetes research and clinical practice
|January 20, 2024
概括
糖尿病外围神经病变 (DPN) 影响了许多糖尿病患者,需要更好的诊断和治疗. 针对DPN的新兴疗法
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病外围神经病变 (DPN) 影响了大约三分之一的糖尿病患者.
- 目前的DPN管理包括生活方式的改变,密集的血糖控制,心血管风险干预,病变导向的药物治疗和症状性疼痛缓解.
- 症状止痛单一疗法具有有限的疗效和潜在的不良反应,突出显示了对新型DPN治疗的未满足需求.
研究的目的:
- 审查糖尿病外围神经病变 (DPN) 的当前和新兴治疗策略.
- 评估病原学方法在预防或改善DPN方面的潜力.
- 评估DPN管理中的特定药物的临床疗效和安全性.
主要方法:
- 对研究DPN治疗的临床前研究和临床试验的审查.
- 对阿尔法-酸,本福胺,actovegin和epalrestat等药物的元分析和随机临床试验 (RCT) 的分析.
- 对关键试验如NATHAN 1对无症状DPN的研究结果的审查.
主要成果:
- 临床前数据表明干扰DPN病理生理学的药物可以预防或改善这种情况.
- 分析和RCT显示了阿尔法脂酸,本福胺,actovegin和epalrestat在有症状的DPN的疗效和安全性.
- 在NATHAN 1试验中,在四年治疗后,无症状的DPN患者的神经病征征有所改善.
结论:
- 几种化合物在症状性DPN治疗中表现出有效性和安全性.
- 这些在不同国家获得授权的代理商对DPN管理有很大的希望.
- 需要进一步的长期临床试验来确定它们作为DPN的单一疗法和组合疗法的价值.
相关概念视频
Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Pathophysiology of Diabetes
940
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
940
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
Dipeptidyl Peptidase 4 Inhibitors
188
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
188
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K


